Kieron Dunleavy, MD

Podcasts

In this interview, we discuss the biology and the therapeutic strategies for primary mediastinal B-cell lymphoma.

Treatment Strategies in Primary Mediastinal B-Cell Lymphoma

Articles

Over recent years, there has been much progress in elucidating the biology of these lymphomas, and this has paved the way for novel therapies that are currently under investigation in clinical trials.

Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone Lymphoma

Chronic lymphocytic leukemia (CLL) is a clonal malignancy that results from expansion of the mature lymphocyte compartment. This expansion is a consequence of prolonged cell survival, despite a varied cell.

Chronic Lymphocytic Leukemia and Hairy-Cell Leukemia

The classification of diffuse large B-cell lymphoma into three distinct molecular diseases--germinal center B-cell–like subtype, an activated B-cell–like subtype, and a primary mediastinal B-cell lymphoma subtype--has laid the foundation for the development of new agents and novel strategies that target individual subtypes.

Author | Kieron Dunleavy, MD

Articles

New content coming soon, please check back later.